Skip to main content
Logo
European Innovation Council
  • private sector

ADmit Therapeutics S.L.

ADmit Therapeutics Logo

Overview

Description

Developer of a medical diagnostic test intended to come up with early detection for Alzheimer's disease. 

The company's diagnostic test is based on an epigenetic analysis in blood samples that covers methylcytosines with next-generation sequencing, enabling medical practitioners to identify Alzheimer's and accelerate the identification of curative drugs in a simplified way.

Website
Founded

2017

Project
Country
  • Spain
Theme
  • Healthcare